NetraMark Holdings Inc. (AIAI.CN)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. George Achilleos | CEO & Director | 265k | -- | -- |
| Mr. Josh Spiegel | President | 403.86k | -- | -- |
| Mr. Daniel Gallucci | Founder, Chief Performance Officer & Director | 32k | -- | 1977 |
| Dr. Joseph Geraci Ph.D. | Founder, Chief Scientific & Technical Officer and Director | 200k | -- | -- |
| Mr. Swapan Kakumanu ACA, ACWA, CGA | Chief Financial Officer | 78k | -- | 1970 |
| Ms. Jaime Hackett | Vice President of Marketing | -- | -- | -- |
| Dr. Luca Pani M.D. | Chief Innovation & Regulatory Officer and Chief Medical Advisor | -- | -- | -- |
| Dr. Kaveh Kavoosi | Head of Progressive Medicine | -- | -- | -- |
| Dr. Larry Alphs | Chief Medical Officer & Member of Advisory Board | -- | -- | -- |
| Dr. Angelico Carta M.D. | Chief Strategy Officer | -- | -- | -- |
NetraMark Holdings Inc.
- Sector:
- Healthcare
- Industry: Health Information Services
Description
NetraMark Holdings Inc. develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada. The company's product suite comprises Netra Shatter; Netra Health Atlas; and NetraAi that is designed to help interact and explore with different perspective of the data for clinical trials. It provides NetraPlacebo module that analyzes past trial data to determine what drives placebo responses to guide inclusion/exclusion criteria; and Netra GPT module that offers insights from past clinical trials about the patient's population by utilizing established medical literature. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. The company was founded in 2016 and is headquartered in Toronto, Canada.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available